Ranbaxy gets FDA nod for Ofloxacin
Ranbaxy Laboratories Ltd (RIL) has received a tentative approval from the US Food and Drug Administration (FDA) to manufacture and market Ofloxacin tablets in 200 mg, 300 mg, and 400 mg,
Ranbaxy Laboratories Ltd (RIL) has received a tentative approval from the US Food and Drug Administration (FDA) to manufacture and market Ofloxacin tablets in 200 mg, 300 mg, and 400 mg,